- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01367015
Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF) (AREDF)
June 3, 2011 updated by: All India Institute of Medical Sciences, New Delhi
A Randomized Clinical Trial on Comparison of Early Versus Late Initiation of Feeding in Preterm Small for Gestation Infants Below 35 Weeks Gestation With Prenatal Absent or Reversal of End Diastolic Flow (AREDF) in Umbilical Artery
The purpose of the study is to compare early versus late initiation of enteral feeding in premature growth restricted babies below the gestational age of 35 weeks born to mothers with prenatal absent or reversal of end diastolic flow in the umbilical artery.
Normally the blood flow from the mother to the baby brings all the nutrients required for growth and the very vital oxygen required for survival.
These deprived babies with poor blood flow adapt to the not so conducive uterine environment by certain adjustments in blood supply to internal organs.
This permits the best possible blood flow to brain heart etc., which are the vital organs and whose adequate functioning is required for survival.
As a consequence, the gut (intestines) gets poor blood supply and hence its appropriate functioning may be jeopardized.
Such 'premature growth restricted' babies are at increased risk of further growth faltering if not fed adequately as also to a condition called 'Necrotising enterocolitis' if fed liberally like other healthy neonates, characterized by abdominal distension, blood in stools and inability to feed for longer durations thereby further affecting growth.
In the past such babies (after birth) were not fed for days together which compromised their growth even further.
It is not clear whether continuing to withhold feeds for prolonged duration will prevent NEC but lead to growth faltering and initiating feeds early will potentiate NEC with further compromised growth and increased morbidity.
There are no randomized trials on feeding strategies in this group of neonates and hence the investigators planned to carry out this study on comparison of early versus delayed initiation of feeding in preterm SGA infants with AREDF.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110029
- Dr Sushma
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 days to 3 days (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Preterm neonates below 35 weeks gestation born at the study center(s)
- Small for gestational age (SGA) ie weight < 10th centile for gestation
- Absent or reverse end diastolic flow (AREDF) in umbilical artery
Exclusion Criteria:
- Babies with major congenital malformations.
- Babies with severe asphyxia as defined by apgar score <4 at 5 min of life with cord/within one hour of life pH< 7.0.
- Shock requiring pressor support at the time of randomization.
- Babies born with gastrointestinal surgical conditions precluding enteral feeding.
- Babies with abdominal distension, bilious or hemorrhagic aspirates or recurrent vomiting at the time of randomization.
- Refusal to obtain consent.
- Gestation below 26 weeks.
- Hydrops fetalis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early Feeding
Early feeding group received minimal enteral feed (MEF) of 8 ml/kg of expressed human milk of the biologic mother for 48 hours after randomization followed by regular feeding with feed increments of 20ml/kg/day to reach 150 ml/kg.
|
Feeding with expressed breast milk @ 8ml/kg/day for 48 hrs after randomization at 60+/-12 hrs of life
|
|
Active Comparator: Late feeding
Late feeding group was kept NPO for a period of 48 hours after randomization followed by minimal enteral feed (MEF) of 8 ml/kg of expressed human milk of the biologic mother for 48 hours and thereafter received regular feeding with feed increments of 20ml/kg/day till full enteral feeds of 150 ml/kg/day were achieved
|
Nil per oral for another 48 hrs after randomization at 60+/-12 hrs of life followed by Feeding with expressed breast milk @ 8ml/kg/day for 48 hrs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days to achieve full feeds defined as 150mL/kg
Time Frame: upto 12 weeks (84 days)
|
First day of the three days when full enteral feeding of 150 ml/kg has been achieved and sustained as recorded from the nursing chart of the neonate
|
upto 12 weeks (84 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days to regain birth weight
Time Frame: upto 16 weeks (112 days)
|
After the initial fall in weight the first day when birth weight is regained or crossed and the value remains above the birth weight for subsequent 2 days will be recorded as day of life birth weight has been regained.
|
upto 16 weeks (112 days)
|
|
Feed intolerance
Time Frame: 12 weeks (84 days)
|
Feed intolerance was measured as number of episodes of any of the following symptoms per infant till he/she reached full feeds of 150ml/kg and sustained it for 2 days.
|
12 weeks (84 days)
|
|
Duration of stay
Time Frame: 12 - 16 weeks (84 - 112 days)
|
This was taken to be the interval between birth and the day the newborn was discharged home.
|
12 - 16 weeks (84 - 112 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Dr Sushma Nangia, MBBS, MD, All India Institute of Medical Sciences, New Delhi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2006
Primary Completion (Actual)
January 1, 2008
Study Completion (Actual)
March 1, 2008
Study Registration Dates
First Submitted
June 1, 2011
First Submitted That Met QC Criteria
June 3, 2011
First Posted (Estimate)
June 6, 2011
Study Record Updates
Last Update Posted (Estimate)
June 6, 2011
Last Update Submitted That Met QC Criteria
June 3, 2011
Last Verified
April 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A-20/ April 2006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity of Fetus
-
Zekai Tahir Burak Women's Health Research and Education...UnknownPrematurity of FetusTurkey
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; German Federal Ministry of Education and Research; Société des Produits Nestlé (SPN)CompletedPrematurity of FetusGermany
-
Nantes University HospitalActive, not recruitingPrematurity of FetusFrance
-
Jean Michel HascoetCompletedPrematurity of FetusFrance
-
St. Louis Children's HospitalWashington University School of Medicine; Genentech, Inc.Completed
-
Holy Family Hospital, Nazareth, IsraelRecruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Meir Medical CenterActive, not recruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Wake Forest University Health SciencesCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Rambam Health Care CampusCompletedInduction of Labor Affected Fetus / NewbornIsrael
-
Intermountain Health Care, Inc.Ferring PharmaceuticalsTerminatedInduction of Labor Affected Fetus / NewbornUnited States
Clinical Trials on Early Feeding
-
Saint Thomas Hospital, PanamaCompletedComplications; Cesarean SectionPanama
-
DHQ mardanDHQ HOSPITAL MARDANCompleted
-
University of Ghana Medical SchoolUnknownCesarean Section ComplicationsGhana
-
Acibadem UniversityCompletedPostoperative Nausea and Vomiting | Patient Satisfaction | Feeding Patterns | Cesarean DeliveryTurkey
-
The Catholic University of KoreaCompleted
-
Icahn School of Medicine at Mount SinaiRecruitingHead and Neck Cancer | Free Tissue TransferUnited States
-
National Taiwan University HospitalEnrolling by invitation
-
RESnTEC, Institute of ResearchCompleted
-
University Hospital, Clermont-FerrandRecruiting